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Non-ossifying  ﬁbromas  (NOFs)  are  common  benign  meta-
physeal  bone  lesions  of  unknown  etiology  that  occur  in
children  and  young  adults  [1].  They  commonly  arise  in  the
distal  femur,  proximal  tibia  and  ﬁbula.  The  peak  incidence
is  between  4—8  years  [2]  and  they  are  often  discovered  inci-
dentally  on  plain  radiographs  [3].  Physical  examination  is
usually  unremarkable.  While  the  vast  majority  of  NOFs  are
asymptomatic,  lesions  causing  chronic  pain  and  pathologic
fractures  have  been  described  [4].
Figure 1. Plain radiograph (a) of the right knee showing an eccentri
margins, consistent with non-ossifying ﬁbromas (NOF). T2-fat-suppressed
a well circumscribed lobulated lesion in the distal metaphysis of the fem






2211-5684/© 2014 Éditions franc¸aises de radiologie. Published by ElsevieNOFs  rarely  require  operative  treatment,  due  to  a  high
ate  of  spontaneous  regression  and  the  lack  of  symptoms
1,2].  Symptomatic  lesions  may  be  treated  non-operatively
3]. If  symptoms  persist,  curettage  and  bone  grafting  have
een  proposed,  although  some  have  reported  an  increased
ecurrence  rate  [4].
We  report  the  case  of  a  17-year-old  female  with  a  symp-
omatic  NOF  treated  by  percutaneous  cryoablation  after
ailure  of  conservative  treatment.
ase  report
 17-year-old  healthy  female  presented  with  distal  right
high  pain  after  a  simple  fall.  Plain  radiographs  of  the  rightc multiloculated radiolucent lesion with sharply deﬁned sclerotic
 (b) and T1 weighted (c) magnetic resonance (MR) imaging showing
ur. The central parts of the lesion appear hyperintense on T2 and
ggestive of NOF. There is no contrast enhancement and no sign of
ypical  features  of  a  NOF  (Fig.  1a).  Pain  persisted  and  limited
er  in  daily  activities.  Magnetic  resonance  (MR)  imaging
eatures  were  consistent  with  a NOF,  with  a  hyperintense






























ignal  on  T2  and  isointense  signal  on  T1  weighted  images
nd  absent  contrast  enhancement.  There  was  no  evidence
f  pathological  fracture  (Fig.  1b—c).  After  1  year  of  persist-
ng  pain,  the  patient  was  referred  to  our  tertiary  medical
enter  for  ongoing  treatment.  Serial  imaging  revealed  no
hange  in  the  lesion.
The  case  was  discussed  at  our  multidisciplinary  tumor
oard  and  percutaneous  cryoablation  was  proposed  as  the
rst  choice  because  of  the  benign  nature  of  the  lesion  and
he  minimal  invasiveness  of  this  procedure.  The  ablation  was
erformed  under  general  anesthesia  on  an  outpatient  basis.
 contemporary  biopsy  was  obtained  to  conﬁrm  the  diag-
osis  (Fig.  2).  Three  Bonopty® bone  biopsy  sets  (AprioMed
B,  Uppsala  Sweden)  were  used  ﬁrst  to  drill  the  cortical
one  under  CT  guidance  and  three  IcespheresTM cryoprobes
Gallil  Medical  Ltd,  Yokneam,  Israel)  were  inserted  into  the
esion  through  the  Bonopty® canula  (Fig.  3).  An  18  gauge
hiba  needle  (Cook  Medical,  Bloomington,  USA)  was  placed
lose  to  the  bone  surface  to  inject  CO2 in  order  to  create
n  insulation  layer  around  the  bone  to  protect  nearby  neu-
ovascular  structures  and  the  skin  during  the  cryoablation
rocess.  Two  cycles  of  12  minutes  freezing,  3 minutes  pas-
ive  thawing  and  2  minutes  active  thawing  were  delivered
o  the  lesion.  The  gases  used  were  Argon  for  freezing  and
elium  for  thawing.
After  the  procedure  the  patient  noted  immediate  pain
elief.  She  was  discharged  home  the  same  day  on  simple
igure 2. Biopsy: spindle non-atypical ﬁbroblasts arranged in
toriform pattern with admixed foamy macrophages (a) and focal
eactive woven bone (b).
Figure 3. 3D image (a) showing the positioning of three
IcespheresTM cryoprobes into the lesion. A needle is visible close
to the bone surface. This needle is used to inject CO2 to create an
























itructures and the skin. Axial CT image (b) showing the CO2 injected
round the bone to protect the neurovascular bundle (arrow).
on-opiate  analgesia  (paracetamol,  mefenamic  acid)  with-
ut  any  mobility  restrictions.  After  1  month,  she  was  pain
ree  and  had  resumed  all  her  daily  activities.  She  was  per-
itted  a  gradual  return  to  sporting  activity.  After  16  months,
lain  radiographs  demonstrated  progressive  ossiﬁcation  of
he  lesion  (Fig.  4).
iscussion
OFs  are  generally  asymptomatic  and  regress  spontaneously
1,2].  Observation  with  serial  annual  or  biennial  plain  radio-
raphs  is  recommended  [3]; when  they  cause  chronic  pain
r  impending  pathologic  fractures,  surgical  curettage  and
utogenous  bone  graft  has  been  proposed  as  the  treatment
f  choice  [4].
To  our  knowledge,  this  is  the  ﬁrst  report  of  cryoablation
s  a  treatment  modality  for  symptomatic  NOF.  Cryoabla-
ion  is  a  minimally  invasive  technique,  well  known  for  the
reatment  of  neoplastic  lesions  in  kidneys,  prostate,  liver
nd  lungs  [5—7].  It  has  also  been  described  in  the  pal-
iative  treatment  of  bone  and  soft  tissue  metastases  [8].
ompared  to  other  ablation  methods,  percutaneous  cryoab-
ation  offers  several  advantages:  it  is  less  invasive  than
pen  surgery,  with  a  better  cosmetic  result,  and  can  eas-
ly  be  performed  on  an  outpatient  basis  [8,9].  In  comparison
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[16 months (b) showing progressive ossiﬁcation of the lesion. The
sclerosis from the periphery toward the center correlates with heal-
ing of the non-ossifying ﬁbroma.
to  percutaneous  radiofrequency  ablation,  cryoablation  may
offer  a  better  control  of  margins  on  CT  or  ultrasound.  Finally,
patients  do  typically  experience  less  pain  in  the  immediate
post-treatment  period  as  compared  to  other  more  invasive
ablation  techniques.  As  we  did  in  the  present  case  a  biopsy
should  always  be  obtained  during  the  procedure  to  conﬁrm
the  diagnosis.
Conclusion
In selected  cases,  particularly  when  there  is  no  risk  of
pathologic  fracture,  percutaneous  cryoablation  may  be  an
acceptable  alternative  to  treat  painful  NOFs.  It  is  mini-
mally  invasive  and  does  not  preclude  additional  treatment.
Further  studies  are  needed  to  conﬁrm  the  validity  of
cryoablation  in  the  treatment  of  selected  benign  bone
lesions.Disclosure  of  interest
The  authors  declare  that  they  have  no  conﬂicts  of  interest
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